Regen Biopharma declares Series A Preferred stock dividend and amends charter

Regen BioPharma Inc

On May 20, 2024, amended Certificate of Incorporation to allow share dividends between classes/series.
Board declared a dividend of 2 shares of Series A Preferred for each share of Common, Series A, AA, M, NC Preferred owned.
Record date: June 20, 2024; payment date: on or about July 1, 2024.
No ticker provided; company is an emerging growth company with no securities registered under Section 12(b).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.